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*Helicobacter cinaedi* is a Gram-negative enterohepatic bacterium of the Helicobacteraceae family that was first identified in 1985 among immunocompromised European and American men with human immunodeficiency virus (HIV) infections (Totten et al. [@CR6]). In Japan, the isolation of *H. cinaedi* from blood culture was first reported in 2003 (Murakami et al. [@CR3]), and it has since been occasionally isolated from samples obtained from patients with bacteremia and sepsis. In this report, we describe our experience with two patients with diabetes who had *H. cinaedi* bacteremia; in addition, we include a literature review.
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Case 1: A 76-year-old female with a history of slowly progressive type 1 diabetes, treated for 30 years. She was being treated for rheumatoid arthritis (oral prednisolone, 5 mg/day, and had poor glycemic control specified by a glycated hemoglobin (HbA1c) level of 7.8% while on a regimen of 50% insulin lispro protamine suspension and 50% insulin lispro injection (HUMALOG® Mix50/50TM; Lilly USA, LLC, 2013) at 6 U in the morning and 4 U in the evening, as well as miglitol (10 mg/day) and mitiglinide (450 mg/day). She presented to the emergency unit of our hospital with a fever of 39°C, headache, erythema on the trunk, and joint pain. On admission, her body temperature was 40.2°C, pulse rate 134 beats/min, blood pressure 150/70 mmHg, height 145 cm, and body weight 38 kg. Routine laboratory testing showed an elevated leukocyte count of 11.8 × 10^3^ cells/μL and a C-reactive protein level of 19.21 mg/dL. Serological tests for syphilis and HIV were negative. As a result, we suspected a bacterial infection, especially because of the significant inflammation reaction in blood sampling; therefore, we decided to begin empiric cefepime therapy at 2 g/day. During hospitalization, our patient complained of a decreased appetite; thus, we commenced blood glucose monitoring on a sliding scale to maintain her preprandial blood glucose level at approximately 120 mg/dL. On day 2 of admission, her fever declined and erythema improved. On day 4, she was discharged after a change to oral cefotiam at 1800 mg/day. On day 9, she again developed high fever, poor appetite, and fatigue, and on day 10, she was readmitted to our hospital. On the same day, *H. cinaedi* was detected from a blood culture taken on the first day of admission; we accordingly started administering minocycline at 200 mg/day. A blood culture taken on the second day of re-admission was positive for *H. cinaedi*, indicating persistent bacteremia. However, because her general condition was improving, oral minocycline (200 mg/day) was continued. On day 18 after the initial admission, the third blood culture was taken, then she was discharged a second time. Later, we confirmed that her third blood culture was negative in an outpatient clinic and prescribed completion of the antibiotic regimen.

Case 2: A 47-year-old female diagnosed with type 2 diabetes 2 years before, and treatment started immediately thereafter. However, after a year, she stopped taking medications on her own decision. She presented to emergency department of our hospital with a fever of 38°C and bilateral lower leg pain for three days. She was hospitalized with a diagnosis of lower right leg cellulitis, and we began cefazolin administration at 3 g/day. On admission, her diabetic control was poor (HbA1c, 11.5%, postprandial blood glucose, 268 mg/dL); in addition, her body temperature was 39.2°C, pulse rate 106 beats/min, blood pressure 137/71 mmHg, height 166 cm, and body weight 61 kg. Routine laboratory testing showed an elevated leukocyte count of 13.8 × 10^3^ cells/μL and a C-reactive protein level of 4.49 mg/dL. Serological tests for syphilis and HIV were negative. Soon after starting antibiotic treatment, her fever subsided. Five days later, redness and swelling disappeared; therefore, we changed treatment to cefdinir at 900 mg/day. She was discharged on day 8. The following day, we confirmed *H. cinaedi* from the blood culture taken on day 1; nevertheless, we decided to adopt a wait-and-see approach because no exacerbation of disease was observed since her initial admission.
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*H. cinaedi* is a rare infection primarily detected among HIV-positive patients in western countries. In Japan, most patients with *H. cinaedi* infection were HIV-negative, but immunocompromised (Araoka et al. [@CR1]). *H. cinaedi* settles in the digestive tracts of humans, monkeys, dogs, and cats. Some cases of hospital-acquired outbreaks have also been reported (Rimbara et al. [@CR5]). Neither of our patients had contact with animals, and because they came from different villages, they had no previous contact each other. Hence, the routes of infection remain unknown. Case 1 was prescribed 5 mg of prednisolone per day for rheumatoid arthritis, and both patients had poorly controlled diabetes. It has been reported that migratory, anti-infection, and phagocytic functions of leukocytes are compromised in patients with diabetes especially by high glucose levels. Therefore, patients with poorly controlled diabetes might be at a higher risk for *H. cinaedi* infection. However, there is no consensus on characteristic clinical symptoms of *H. cinaedi* infection and *H. cinaedi* is a fastidious organism, thereby making it difficult to clinically diagnosis.

The average separation and processing period of a blood culture to detect H. cinaedi is 5 days (Araoka et al. [@CR1]), and the frequency of positive blood culture samples is reported to be 0.22% (Araoka et al. [@CR1]). The actual frequency is probably higher because culturing this organism is difficult. Other reports have advocated genetic analyses, such as 16S-rRNA sequence and PCR-restriction fragment length polymorphism analyses (Oyama et al. [@CR4]), for definitive diagnosis, although these methods are not feasible for routine laboratory analysis due to imbalance in cost--benefit ratio to detect very rare organisms. No guidelines have been provided for the treatment of *H. cinaedi* infections, even though this organism is reportedly sensitive to many antibiotics. In general, cephalosporins, carbapenems, tetracyclines, and aminoglycosides were found to be effective; however, various *H. cinaedi* isolates in Japan have shown increased resistance to penicillins and resistance to macrolides and quinolones (Kawamura et al. [@CR2]). Therefore, some cases of *H. cinaedi* bacteremia may require long-term administration of multiple antibiotics prior to the resolution of infection.

In conclusion, two patients with poorly controlled diabetes presented with *H. cinaedi* bacteremia. Because *H. cinaedi* develops no characteristic clinical symptoms, it is important to consider *H. cinaedi* infection, especially in patients with poorly controlled diabetes who experience a relapse of infection after curative antibiotic treatment.
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